Dexcom Stock - Sunday background on the glucose-sensor specialist
21.06.2026 - 12:43:06 | ad-hoc-news.de
Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 10:30 UTC. Details in the imprint.
Dexcom Inc. (US2521311074) is one of the most closely watched diabetes-technology names on the Nasdaq, best known for its continuous glucose monitoring systems for people with diabetes. With no new market-moving announcements this weekend, the focus shifts to a broader Sunday background on the business and its stock profile.
Background and data on Dexcom stock
Key figures, news flow and filings around Dexcom stock can be followed on our topic page and via the company’s own investor relations materials.
What recent data show
Dexcom stock trades on the Nasdaq under the ticker DXCM and closed at $72.47 on 06/18/2026, according to MarketBeat data based on Nasdaq figures. Extended trading that evening showed a quote of $73.40, implying a modest after-hours gain.
From the start of 2026, when Dexcom shares were at $66.37, the stock has risen about 9.2% year-to-date to that $72.47 close. Over roughly the last 30 days, separate technical-data services indicate the stock is slightly higher, with a move of around 0.5% over that span.
Sunday background on the business
Dexcom is widely recognized as a leader in continuous glucose monitoring, offering wearable sensors that transmit glucose data to receivers or smartphones. Its systems are aimed primarily at people with type 1 and insulin-treated type 2 diabetes, where real-time data can help improve day-to-day glucose control.
The company’s growth over the past decade has been driven by broader CGM adoption, reimbursement expansion and new product generations. Industry coverage often highlights Dexcom in the context of the broader diabetes technology space, alongside insulin-pump makers and competing sensor providers, with many investors treating CGM penetration as a long-term structural driver.
The product behind the stock
Dexcom generates most of its revenue from the Dexcom G7 continuous glucose monitoring system, a small wearable sensor and transmitter that send glucose readings to a display device or smartphone app. The system is designed to replace routine fingerstick tests for many insulin-treated patients.
Where the stock trades today
Dexcom shares (US2521311074) most recently traded on the Nasdaq at $72.47 as of the close on 06/18/2026, based on available exchange data in US dollars.
Key facts on Dexcom stock
- Company: DexCom, Inc.
- ISIN: US2521311074
- WKN: A0D9T1
- Ticker: DXCM
- Venue: Nasdaq
- Price (as of 06/18/2026, 16:00 ET): 72.47 USD
- Market cap: around 28 billion USD (mid-2026 levels based on recent quotations)
- Sector / Industry: Health Care / Medical Devices
- Index membership: Standard & Poor's 500 index
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
